+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sleep Aids Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sleep Aids Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Sleep Aids Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082575
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sleep Aids Market grew from USD 64.15 billion in 2024 to USD 67.91 billion in 2025. It is expected to continue growing at a CAGR of 5.63%, reaching USD 89.16 billion by 2030.

Over the past decade, the pursuit of restorative sleep has transcended from a simple nightly ritual to a complex quest driven by evolving lifestyles, technological breakthroughs, and growing awareness of sleep’s vital role in health. As stress levels rise and screen time extends deep into the evening hours, individuals increasingly seek targeted solutions that not only induce slumber but also improve sleep quality. Innovations in digital therapeutics, nutraceuticals, and wearable technologies have converged to create a multifaceted ecosystem, where cognitive behavioral therapy applications coexist alongside herbal supplements and prescription medications.

This report opens with a comprehensive overview of the current sleep aids market, highlighting the forces shaping demand, supply chains, and consumer preferences. By examining how demographic shifts, regulatory changes, and global economic trends intersect with the science of sleep, readers will gain a holistic view of the challenges and opportunities ahead. Subsequent sections delve into the transformative trends redefining product categories, the ripple effects of new tariffs, and actionable recommendations for stakeholders eager to navigate this dynamic environment.

Ultimately, this executive summary sets the stage for an in-depth exploration of market dynamics, empowering decision-makers to craft data-driven strategies that resonate with end users and drive sustainable growth.

Transformative Shifts Shaping the Sleep Aids Market

Advancements in digital therapeutics have revolutionized how consumers manage sleep disorders. Mobile apps offering guided audio therapies and interactive behavioral modules now rival traditional in-office interventions. At the same time, wearable devices have evolved from basic sleep trackers to smart headbands capable of monitoring brainwave patterns in real time, delivering personalized feedback on sleep stages and environmental adjustments.

Concurrently, the rise of telehealth platforms has enabled remote consultations with sleep specialists, accelerating access to prescription and non-pharmacological remedies. Emerging research into botanical compounds has spurred a renaissance in herbal sleep aids, with formulations containing chamomile, lavender, and valerian root gaining traction for their purported calming effects. Nutraceutical companies have also fortified these blends with melatonin and select vitamins to optimize circadian regulation.

Meanwhile, healthcare providers are increasingly integrating cognitive behavioral therapy for insomnia into holistic treatment plans. As insurers begin to recognize the long-term cost savings of improved sleep, reimbursement models are adapting to support digital CBT solutions. The cumulative effect of these shifts is the creation of a market that values personalization, convenience, and scientifically validated efficacy, setting new benchmarks for product development and patient engagement.

Cumulative Impact of U.S. Tariffs in 2025 on Sleep Aids

In response to regulatory directives in early 2025, the United States implemented new tariffs targeting imported sleep-aid ingredients, medical devices, and wearable components. This policy initiative aimed to bolster domestic manufacturing but introduced immediate cost pressures for suppliers reliant on global value chains. Manufacturers of smart headbands and high-precision sleep trackers, for example, faced increased duties on semiconductor assemblies sourced from Asia-Pacific, while producers of herbal extracts encountered steeper import fees on raw botanicals.

These fiscal adjustments prompted several strategic responses. Some companies opted to relocate assembly lines closer to end markets, accelerating efforts to nearshore production facilities. Others forged supplier partnerships in regions less affected by the new duties, diversifying risk by creating multi-tiered procurement networks. At the same time, product developers recalibrated ingredient blends to incorporate more locally sourced extracts, reducing exposure to imported components.

Retailers and e-commerce platforms absorbed a portion of the additional costs to maintain competitive pricing, though some premium brands adjusted price structures to preserve margins. Regulatory agencies also introduced streamlined approval pathways for domestically manufactured products, incentivizing investment in homegrown technology. As a result, the tariff measures have not only reshaped cost models but also catalyzed innovation in supply chain resilience and product localization.

Key Segmentation Insights Driving Market Dynamics

An in-depth examination of product type segmentation reveals distinct growth drivers across cognitive behavioral therapy solutions, over-the-counter sleep aids, prescription medications, and wearable devices. Within cognitive behavioral therapy products, digital apps have surged in popularity, complemented by guided audio programs that facilitate at-home treatment. Over-the-counter sleep aids encompass antihistamines, herbal formulations, and melatonin supplements, with the herbal category further refined into chamomile, lavender, and valerian root extracts to meet consumer demand for natural remedies.

Across demographic groups, adult and senior segments demonstrate the highest propensity to adopt prescription sleep medications-divided between benzodiazepines and non-benzodiazepines-while younger users gravitate toward wearable trackers and mobile interventions. Gender and income levels further nuance usage patterns, with high-income consumers often drawn to premium smart headbands and personalized digital CBT subscriptions, whereas budget options in capsule and tablet form resonate more with cost-conscious buyers.

Sleep disorder segmentation shows chronic and short-term insomnia treatments dominating the market, while solutions for narcolepsy, restless legs syndrome, and both central and obstructive sleep apnea drive specialized device development. Distribution channels span hospital pharmacies, online retailers, pharmaceutical stores, and large-format supermarkets, each playing a unique role in product accessibility. Ingredient types also bifurcate into natural and synthetic, with natural offerings subdivided into herbal and vitamins & minerals, and formulations ranging from capsules and tablets to liquids and powders. Finally, purchase motivations split between lifestyle enhancement and medical necessity, influencing brand positioning across both budget and premium price tiers.

Regional Trends Influencing Sleep Aids Adoption

Regional dynamics in the Americas underscore robust demand for digital sleep interventions, where widespread broadband access and favorable reimbursement policies fuel growth in telehealth-delivered cognitive therapies. Latin American markets show a parallel uptick in herbal supplement adoption, reflecting long-standing cultural affinities for plant-based remedies.

In Europe, Middle East & Africa, consumers navigate a spectrum of regulatory environments that shape product approval timelines and labeling requirements. Western Europe leads in wearable device adoption, supported by a tech-savvy population and comprehensive healthcare frameworks that subsidize select prescription options. In contrast, Middle Eastern markets witness growing interest in premium sleep solutions among high-income demographics, while African nations prioritize cost-effective over-the-counter formulations due to price sensitivities.

Across Asia-Pacific, burgeoning middle classes in countries such as China and India drive volume sales of melatonin supplements and affordable sleep trackers. Meanwhile, Japan and Australia represent mature arenas for non-benzodiazepine prescription medications and advanced smart headband technologies. Regulatory harmonization efforts and expanding distribution networks are poised to further integrate these regional markets, creating opportunities for cross-border collaborations and unified product standards.

Competitive Landscape: Leading Sleep Aids Innovators

The competitive landscape is defined by a blend of established medical device manufacturers, pharmaceutical giants, and emerging digital health innovators. Apnea Sciences Corporation and ResMed Inc. maintain leadership in sleep apnea solutions, leveraging advanced diagnostic algorithms and integrated therapy platforms. Koninklijke Philips N.V. and Fisher & Paykel Healthcare Corp. Ltd. continue to invest in next-generation ventilator and mask designs, emphasizing user comfort and remote monitoring capabilities.

In the medication segment, Pfizer Inc., Merck and Co. Inc., and Sanofi S.A. dominate with well-known non-benzodiazepine and benzodiazepine portfolios, while Eisai Co., Ltd. pioneers novel formulations combining synthetic and herbal constituents. On the digital front, Compumedics Limited and Nihon Kohden Corporation bring hospital-grade polysomnography systems to market, whereas Cadwell Industries Inc. and Natus Medical Inc. cater to diagnostic centers with specialized neurophysiological monitoring tools.

Emerging players such as Drive DeVilbiss Healthcare Inc. and Cleveland Medical Devices Inc. differentiate through modular, home-use platforms, challenging traditional care settings. Across the board, leading organizations are forging partnerships, investing in R&D labs, and acquiring startups to bolster their sleep-tech capabilities. This dynamic competitive environment underscores the imperative for continuous innovation and strategic alliances to secure market share.

Actionable Recommendations for Industry Leaders

Industry participants should prioritize the development of integrated digital-to-device solutions that seamlessly combine behavioral interventions with real-time sleep analytics. Strengthening supplier diversification strategies will mitigate exposure to future tariff adjustments, ensuring uninterrupted access to critical components and raw materials. Firms can also drive differentiation by formulating hybrid offerings that blend natural extracts like chamomile and valerian root with evidence-backed synthetic actives, appealing to both wellness enthusiasts and clinically-focused practitioners.

Expanding telehealth partnerships with insurers and healthcare systems will unlock new reimbursement pathways for digital cognitive behavioral therapies, while pilot programs in corporate wellness initiatives can showcase measurable improvements in employee productivity and health outcomes. Regional expansion efforts should focus on aligning product portfolios with local regulatory standards in markets such as the Middle East and Asia-Pacific, where tailored labeling and distribution strategies improve market entry success.

Finally, forging strategic alliances with research institutions and technology startups can accelerate the adoption of next-generation wearable headbands and smart sleep environments. By acting on these recommendations, industry leaders will strengthen competitive positioning and foster resilient growth amid evolving market dynamics.

Conclusion: Capitalizing on Emerging Opportunities

The sleep aids sector stands at a pivotal moment, shaped by regulatory shifts, technological breakthroughs, and changing consumer preferences. Companies that embrace a holistic approach-integrating digital therapeutics, personalized formulations, and supply chain resilience-will lead the next wave of innovation. As tariff landscapes evolve, agility in procurement and production will differentiate winners from laggards.

In this transformative environment, collaboration between pharmaceutical developers, device manufacturers, and digital health providers will unlock new synergies. Targeted investments in R&D, paired with a keen understanding of regional market nuances, will enable stakeholders to deliver compelling value propositions to diverse user segments. Ultimately, the convergence of science, technology, and consumer-centric design promises to elevate sleep health as a mainstream priority, driving both commercial success and societal well­being.

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cognitive Behavioral Therapy Products
    • Digital Apps
    • Guided Audios
  • Over-The-Counter Sleep Aids
    • Antihistamines
    • Herbal Sleep Aids
      • Chamomile
      • Lavender
      • Valerian Root
    • Melatonin Supplements
  • Prescription Sleep Medication
    • Benzodiazepines
    • Non-Benzodiazepines
  • Wearable Sleep Aids
    • Sleep Trackers
    • Smart Headbands
  • Age Group
    • Adults
    • Senior Citizens
    • Teenagers
  • Gender
    • Female
    • Male
  • Income Level
    • High Income
    • Low Income
    • Middle Income
  • Insomnia
    • Chronic Insomnia
    • Short-Term Insomnia
  • Narcolepsy
  • Restless Legs Syndrome
  • Sleep Apnea
    • Central Sleep Apnea
    • Obstructive Sleep Apnea
  • Hospital Pharmacies
  • Online Retailers
  • Pharmaceutical Stores
  • Supermarkets/Hypermarkets
  • Natural Ingredients
    • Herbal
    • Vitamins & Minerals
  • Synthetic Ingredients
  • Capsules & Tablets
  • Liquid Form
  • Powders
  • Lifestyle Enhancement
  • Medical Condition
  • Budget Options
  • Premium Options

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Sleep Aids Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Apnea Sciences Corporation
  • Boehringer Ingelheim International GmbH
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips N. V.
  • Merck and Co. Inc.
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi S.A.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sleep Aids Market, by Product Type
8.1. Introduction
8.2. Cognitive Behavioral Therapy Products
8.2.1. Digital Apps
8.2.2. Guided Audios
8.3. Over-The-Counter Sleep Aids
8.3.1. Antihistamines
8.3.2. Herbal Sleep Aids
8.3.2.1. Chamomile
8.3.2.2. Lavender
8.3.2.3. Valerian Root
8.3.3. Melatonin Supplements
8.4. Prescription Sleep Medication
8.4.1. Benzodiazepines
8.4.2. Non-Benzodiazepines
8.5. Wearable Sleep Aids
8.5.1. Sleep Trackers
8.5.2. Smart Headbands
9. Sleep Aids Market, by User Demographics
9.1. Introduction
9.2. Age Group
9.2.1. Adults
9.2.2. Senior Citizens
9.2.3. Teenagers
9.3. Gender
9.3.1. Female
9.3.2. Male
9.4. Income Level
9.4.1. High Income
9.4.2. Low Income
9.4.3. Middle Income
10. Sleep Aids Market, by Sleep Disorders
10.1. Introduction
10.2. Insomnia
10.2.1. Chronic Insomnia
10.2.2. Short-Term Insomnia
10.3. Narcolepsy
10.4. Restless Legs Syndrome
10.5. Sleep Apnea
10.5.1. Central Sleep Apnea
10.5.2. Obstructive Sleep Apnea
11. Sleep Aids Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Retailers
11.4. Pharmaceutical Stores
11.5. Supermarkets/Hypermarkets
12. Sleep Aids Market, by Ingredient Type
12.1. Introduction
12.2. Natural Ingredients
12.2.1. Herbal
12.2.2. Vitamins & Minerals
12.3. Synthetic Ingredients
13. Sleep Aids Market, by Formulation Type
13.1. Introduction
13.2. Capsules & Tablets
13.3. Liquid Form
13.4. Powders
14. Sleep Aids Market, by Purchase Reason
14.1. Introduction
14.2. Lifestyle Enhancement
14.3. Medical Condition
15. Sleep Aids Market, by Price Range
15.1. Introduction
15.2. Budget Options
15.3. Premium Options
16. Americas Sleep Aids Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Sleep Aids Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Sleep Aids Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Apnea Sciences Corporation
19.3.2. Boehringer Ingelheim International GmbH
19.3.3. Cadwell Industries Inc.
19.3.4. Cleveland Medical Devices Inc.
19.3.5. Compumedics Limited
19.3.6. Drive DeVilbiss Healthcare Inc.
19.3.7. Eisai Co., Ltd.
19.3.8. Fisher & Paykel Healthcare Corp. Ltd.
19.3.9. Koninklijke Philips N. V.
19.3.10. Merck and Co. Inc.
19.3.11. Natus Medical Inc.
19.3.12. Nihon Kohden Corporation
19.3.13. Pfizer Inc.
19.3.14. ResMed Inc.
19.3.15. Sanofi S.A.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. SLEEP AIDS MARKET MULTI-CURRENCY
FIGURE 2. SLEEP AIDS MARKET MULTI-LANGUAGE
FIGURE 3. SLEEP AIDS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SLEEP AIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY DIGITAL APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY GUIDED AUDIOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SLEEP AIDS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SLEEP AIDS MARKET SIZE, BY CHAMOMILE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SLEEP AIDS MARKET SIZE, BY LAVENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SLEEP AIDS MARKET SIZE, BY VALERIAN ROOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SLEEP AIDS MARKET SIZE, BY MELATONIN SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SLEEP AIDS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SLEEP AIDS MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP TRACKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SLEEP AIDS MARKET SIZE, BY SMART HEADBANDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SLEEP AIDS MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SLEEP AIDS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SLEEP AIDS MARKET SIZE, BY SENIOR CITIZENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SLEEP AIDS MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SLEEP AIDS MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SLEEP AIDS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SLEEP AIDS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SLEEP AIDS MARKET SIZE, BY HIGH INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SLEEP AIDS MARKET SIZE, BY LOW INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SLEEP AIDS MARKET SIZE, BY MIDDLE INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SLEEP AIDS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SLEEP AIDS MARKET SIZE, BY CHRONIC INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SLEEP AIDS MARKET SIZE, BY SHORT-TERM INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SLEEP AIDS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SLEEP AIDS MARKET SIZE, BY RESTLESS LEGS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SLEEP AIDS MARKET SIZE, BY CENTRAL SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SLEEP AIDS MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SLEEP AIDS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SLEEP AIDS MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SLEEP AIDS MARKET SIZE, BY PHARMACEUTICAL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SLEEP AIDS MARKET SIZE, BY SUPERMARKETS/HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SLEEP AIDS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SLEEP AIDS MARKET SIZE, BY SYNTHETIC INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SLEEP AIDS MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SLEEP AIDS MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SLEEP AIDS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SLEEP AIDS MARKET SIZE, BY LIFESTYLE ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICAL CONDITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SLEEP AIDS MARKET SIZE, BY BUDGET OPTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SLEEP AIDS MARKET SIZE, BY PREMIUM OPTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 133. CANADA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. CANADA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 135. CANADA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 136. CANADA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 137. CANADA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 138. CANADA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 139. CANADA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 140. CANADA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. CANADA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 142. CANADA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 143. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 144. CANADA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 145. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 146. CANADA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. CANADA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. CANADA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 149. CANADA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 150. CANADA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 151. CANADA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 152. MEXICO SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. MEXICO SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 157. MEXICO SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. MEXICO SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 161. MEXICO SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 162. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 164. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 165. MEXICO SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. MEXICO SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 169. MEXICO SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 170. MEXICO SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 230. CHINA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. CHINA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. CHINA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 233. CHINA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 234. CHINA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 235. CHINA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 236. CHINA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 237. CHINA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. CHINA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 239. CHINA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 240. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 241. CHINA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 242. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 243. CHINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. CHINA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. CHINA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 246. CHINA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 248. CHINA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 249. INDIA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. INDIA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 251. INDIA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 252. INDIA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 253. INDIA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 254. INDIA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 255. INDIA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 256. INDIA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. INDIA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 258. INDIA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 259. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 260. INDIA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 261. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 262. INDIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. INDIA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. INDIA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 265. INDIA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. INDIA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 267. INDIA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 289. JAPAN SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 290. JAPAN SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 292. JAPAN SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 295. JAPAN SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 296. JAPAN SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 297. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 298. JAPAN SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 299. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 300. JAPAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. JAPAN SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 302. JAPAN SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 303. JAPAN SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 304. JAPAN SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 305. JAPAN SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. MALAYSIA SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. MALAYSIA SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 322. MALAYSIA SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 323. MALAYSIA SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE SLEEP AIDS MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE SLEEP AIDS MARKET SIZE, BY HERBAL SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRESCRIPTION SLEEP MEDICATION, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE SLEEP AIDS MARKET SIZE, BY WEARABLE SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE SLEEP AIDS MARKET SIZE, BY USER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE SLEEP AIDS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE SLEEP AIDS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE SLEEP AIDS MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 354. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 355. SINGAPORE SLEEP AIDS MARKET SIZE, BY INSOMNIA, 2018-2030 (USD MILLION)
TABLE 356. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 357. SINGAPORE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 358. SINGAPORE SLEEP AIDS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 359. SINGAPORE SLEEP AIDS MARKET SIZE, BY NATURAL INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 360. SINGAPORE SLEEP AIDS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 361. SINGAPORE SLEEP AIDS MARKET SIZE, BY PURCHASE REASON, 2018-2030 (USD MILLION)
TABLE 362. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 363. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 364. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 365. SOUTH KORE

Companies Mentioned

  • Apnea Sciences Corporation
  • Boehringer Ingelheim International GmbH
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips N. V.
  • Merck and Co. Inc.
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi S.A.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Sleep Aids Market by Product, Sleep-Disorder, Distribution Channel - Global Forecast 2025-2030 - Product Image

Sleep Aids Market by Product, Sleep-Disorder, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Insomnia Pharmacological Treatment Market by Drug, Treatment, Distribution Channel - Global Forecast 2025-2030 - Product Image

Insomnia Pharmacological Treatment Market by Drug, Treatment, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Sleep Aid - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Sleep Aid - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Sleeping Aids - Global Strategic Business Report - Product Image

Sleeping Aids - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Sleeping Aids - A Global Market Overview - Product Image

Sleeping Aids - A Global Market Overview

  • Report
  • 220 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.